| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | David M Kaye | |
| Justin A Mariani | |||
| P2860 | cites work | Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 |
| Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium | Q30486444 | ||
| Transcoronary transplantation of progenitor cells after myocardial infarction | Q30824315 | ||
| Monitoring of bone marrow cell homing into the infarcted human myocardium | Q31162853 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial | Q33151955 | ||
| Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial | Q33263365 | ||
| AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts | Q33338764 | ||
| Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease | Q33490304 | ||
| The effect of cardiopulmonary lymphatic obstruction on heart and lung function | Q34177622 | ||
| Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade | Q34191737 | ||
| The venous drainage of the human myocardium. | Q35088442 | ||
| Current concepts and applications of coronary venous retroinfusion | Q35926945 | ||
| Targeted high-efficiency, homogeneous myocardial gene transfer | Q35990749 | ||
| Ultrarapid, highly efficient viral gene transfer to the heart | Q36144261 | ||
| Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair | Q36327602 | ||
| Cardiac resynchronisation therapy for heart failure | Q36393860 | ||
| Catheter-based stem cell and gene therapy for refractory myocardial ischemia | Q36710767 | ||
| Stem cell therapy for heart failure: are arrhythmias a real safety concern? | Q37496407 | ||
| The momentum of coronary sinus interventions clinically | Q39625447 | ||
| Retrograde cardioplegia via the coronary sinus. | Q39774002 | ||
| Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent. | Q40275091 | ||
| Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. | Q40569551 | ||
| Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction | Q40745277 | ||
| Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters | Q40871756 | ||
| Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium | Q42492663 | ||
| Exploring heart lymphatics in local drug delivery | Q43537777 | ||
| Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein | Q43590637 | ||
| Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery | Q43670453 | ||
| In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo | Q43856052 | ||
| Incomplete retention after direct myocardial injection | Q44025280 | ||
| Size of coronary sinus at necropsy in subjects without cardiac disease and in patients with various cardiac conditions | Q44285784 | ||
| Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure | Q44411377 | ||
| Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. | Q44538164 | ||
| Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up | Q44697038 | ||
| Recombinant adeno-associated virus vector for gene transfer to the transplanted rat heart. | Q45405632 | ||
| Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres | Q45858433 | ||
| Gene delivery to the myocardium by intrapericardial injection. | Q45862161 | ||
| T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. | Q45866838 | ||
| Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals | Q45869517 | ||
| Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors | Q45872017 | ||
| Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter | Q45877083 | ||
| Cardiac gene delivery with cardiopulmonary bypass | Q45878576 | ||
| Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals | Q45879221 | ||
| Catheter-mediated subselective intracoronary gene delivery to the rabbit heart: introduction of a novel method | Q45880560 | ||
| Thoracoscopic monitoring for pericardial application of local drug or gene therapy | Q45883536 | ||
| Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin | Q45889788 | ||
| Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. | Q45958753 | ||
| Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart | Q46137438 | ||
| Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. | Q46375274 | ||
| Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium. Optimization of the delivery technique. | Q46515972 | ||
| Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route. | Q46558876 | ||
| Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials | Q46700937 | ||
| Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution | Q47630622 | ||
| Nonfluoroscopic, in vivo navigation and mapping technology | Q48853952 | ||
| Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. | Q50499671 | ||
| Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. | Q50688973 | ||
| The cardiac lymphatics. | Q50972838 | ||
| Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. | Q50981942 | ||
| Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. | Q51140442 | ||
| Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. | Q51156709 | ||
| Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. | Q51221148 | ||
| Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. | Q53410907 | ||
| Noninvasive visualization of the cardiac venous system using multislice computed tomography. | Q53593489 | ||
| Myoblast transplantation for heart failure | Q58109127 | ||
| Selective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia | Q59261110 | ||
| Efficient myocyte gene delivery with complete cardiac surgical isolation in situ | Q64378298 | ||
| Conditions of vector delivery improve efficiency of adenoviral-mediated gene transfer to the transplanted heart | Q64379857 | ||
| Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis | Q64380951 | ||
| Ex vivo adenovirus-mediated gene transfer to the adult rat heart | Q64382126 | ||
| Intrapericardial administration of adenovirus for gene transfer | Q64382593 | ||
| Retrograde cardioplegia does not adequately perfuse the right ventricle | Q72301685 | ||
| A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results | Q73267303 | ||
| Increased Intramural Retention After Local Delivery of Molecules with Increased Binding Properties: Implications for Regional Delivery of Pharmacologic Agents | Q73468997 | ||
| Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation | Q73506894 | ||
| Intrapericardial therapeutics and diagnostics | Q73665614 | ||
| Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution | Q73986215 | ||
| Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia | Q74250139 | ||
| Angiographic anatomy of the coronary sinus and its tributaries | Q77589234 | ||
| ANATOMY OF THE CORONARY CIRCULATION IN LIVING MAN; CORONARY VENOGRAPHY | Q78301886 | ||
| Non-invasive visualization of the cardiac venous system in coronary artery disease patients using 64-slice computed tomography | Q79328887 | ||
| Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease | Q79886155 | ||
| Short-term heart retention and distribution of intramyocardial delivered mesenchymal cells within necrotic or intact myocardium | Q80084658 | ||
| Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function | Q80557774 | ||
| Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease | Q82727493 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 417-426 | |
| P577 | publication date | 2010-05-11 | |
| P1433 | published in | Journal of Cardiovascular Translational Research | Q6294906 |
| P1476 | title | Delivery of gene and cellular therapies for heart disease | |
| P478 | volume | 3 |
| Q37982681 | Adjuvant early and late cardioprotective therapy: access to the heart. |
| Q26797153 | Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria |
| Q34994526 | Engineering and visualization of bacteria for targeting infarcted myocardium |
| Q26863362 | Gene delivery technologies for cardiac applications |
| Q37857290 | Gene therapy for ischemic heart disease. |
Search more.